Exacerbation and pneumonia risk models: methodology and results from the IMPACT trial

B. Hartley (Twickenham, United Kingdom), S. Lettis (Uxbridge, United Kingdom), D. Lipson (Collegeville and Philadelphia, United States of America), P. Jones (Brentford, United Kingdom), C. Crim (Research Triangle Park, NC, United States of America), M. Dransfield (Birmingham, AL, United States of America), D. Singh (Manchester, United Kingdom), N. Martin (Brentford and Leicester, United Kingdom), N. Barnes (Brentford and London, United Kingdom)

Source: International Congress 2019 – Exacerbations of airway diseases
Session: Exacerbations of airway diseases
Session type: Poster Discussion
Number: 5230
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Hartley (Twickenham, United Kingdom), S. Lettis (Uxbridge, United Kingdom), D. Lipson (Collegeville and Philadelphia, United States of America), P. Jones (Brentford, United Kingdom), C. Crim (Research Triangle Park, NC, United States of America), M. Dransfield (Birmingham, AL, United States of America), D. Singh (Manchester, United Kingdom), N. Martin (Brentford and Leicester, United Kingdom), N. Barnes (Brentford and London, United Kingdom). Exacerbation and pneumonia risk models: methodology and results from the IMPACT trial. 5230

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Risk factors of re-hospitalisation for a COPD exacerbation: a prospective study
Source: Eur Respir J 2002; 20: Suppl. 38, 402s
Year: 2002

Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021


Challenges in classification of asthma severity from prescription data: a pilot study
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009


Prevalence of COPD: updated meta-analysis results
Source: Annual Congress 2007 - Environmental and clinical aspects of COPD
Year: 2007


Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021


Patients’ adherence to chronic treatment in lung diseases: Preliminary data from a randomized controlled trial
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016

Thrombocytosis predicts poor outcomes in patients with community-acquired pneumonia: results from the CAPO international cohort study
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008

Risk factors associated with frequent exacerbations (FE) in severe asthma: a multicentre study in Japan
Source: Annual Congress 2009 - Severe asthma and its treatment
Year: 2009


Incidence and risk factors for acute exacerbations of asthma during pregnancy: A prospective observational study of 500 pregnancies
Source: Annual Congress 2013 –Highlights in epidemiology of respiratory disease
Year: 2013

COPD therapy based on clinical phenotypes: Baseline data from the Czech multicentre research database of COPD
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015


A prediction model for exacerbations in patients with COPD generated in a Swiss multicenter COPD cohort study (TOPDOCS)
Source: International Congress 2017 – Primary care management of asthma and COPD
Year: 2017


An Italian, observational, multicentre trial to describe treatment management in COPD patients: Preliminary results of the MISTRAL study
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014


Incidence and risk factors of pediatric asthma exacerbations in a multinational, multidatabase cohort study
Source: International Congress 2018 – New developments in paediatric asthma
Year: 2018




Performance indicators to evaluate the management of patients with ventilator-associated pneumonia: results from the IMPACT-HAP study group
Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens
Year: 2008


Risk of bias in COPD trials
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008

Risk of pneumonia related to budesonide use in COPD: An updated pooled analysis
Source: Annual Congress 2012 - COPD treatments: efficacy and safety
Year: 2012


Identifying patients at risk for future exacerbations of asthma: Development of a prediction model
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015

ICS and risk of pneumonia in Swedish COPD patients: The ARCTIC study
Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care
Year: 2016

Impact of patients’ setting on the prevalence of pulmonary embolism in acute exacerbation of COPD : a meta-analysis of observational studies.
Source: International Congress 2017 – Pulmonary embolism
Year: 2017

Case fatality of COPD exacerbations: a meta-analysis and modelling approach
Source: Annual Congress 2009 - Epidemiology of COPD
Year: 2009